Suppr超能文献

[0.1%和0.03%阿达帕林凝胶与0.025%维甲酸凝胶治疗痤疮的疗效和耐受性比较研究]

[Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].

作者信息

Alirezai M, Meynadier J, Jablonska S, Czernielewski J, Verschoore M

机构信息

Clinique de Dermatologie, CHU de Montpellier.

出版信息

Ann Dermatol Venereol. 1996;123(3):165-70.

PMID:8761775
Abstract

INTRODUCTION

Adapalene is a new chemical entity with retinoid activity.

PATIENTS AND METHODS

0.1 p. 100 adapalene gel (Différine gel), 0.03 p. 100 adapalene gel and a commercially available 0.025 p. 100 tretinoin gel (Aberel gel) were compared in 89 male and female patients with acne.

RESULTS

Inflammatory, non inflammatory, total lesion counts, and the global facial acne grade regularly decreased as a function of time in the three treatment groups. No statistically or clinicaly significant differences were observed for these parameters between 0.1 p. 100 adapalene gel and 0.025 p. 100 tretinoin gel following a 12-week treatment. Conversely, both of these gels were significantly more effective than 0.03 p. 100 adapalene gel with regards to inflammatory and total lesion counts, and the global facial acne grade. The differences of efficacy seen between both adapalene gels demonstrate a dose-dependent activity of the drug in the topical treatment of acne. The three products induced retinoid-like skin irritation with significant differences in intensity in favour of adapalene for erythema, dryness, scaling and burning after application and in favour of tretinoin for persistent burning. No treatment-related medical events were reported and adapalene plasma levels were lower than 0.15 ng/ml (limit of detection of the analytical method).

CONCLUSIONS

The topical treatment of acne with adapalene gels was found to be safe and effective, with a dose-related response. The efficacy of 0.1 p. 100 adapalene gel and of 0.025 p. 100 tretinoin gel are not different but skin tolerance of 0.1 p. 100 adapalene gel is superior.

摘要

引言

阿达帕林是一种具有类维生素A活性的新型化学物质。

患者与方法

对89例痤疮男女患者比较了0.1%阿达帕林凝胶(达芙文凝胶)、0.03%阿达帕林凝胶和市售0.025%维甲酸凝胶(阿贝瑞凝胶)。

结果

三个治疗组的炎症性、非炎症性、总皮损计数及面部整体痤疮分级均随时间有规律地下降。12周治疗后,0.1%阿达帕林凝胶与0.025%维甲酸凝胶在这些参数上未观察到统计学或临床显著差异。相反,就炎症性和总皮损计数以及面部整体痤疮分级而言,这两种凝胶均显著优于0.03%阿达帕林凝胶。两种阿达帕林凝胶之间的疗效差异表明该药物在痤疮局部治疗中具有剂量依赖性活性。三种产品均引起类维生素A样皮肤刺激,在红斑、干燥、脱屑和用药后烧灼感方面强度差异显著,阿达帕林更具优势,而在持续性烧灼感方面维甲酸更具优势。未报告与治疗相关的医疗事件,且阿达帕林血浆水平低于0.15 ng/ml(分析方法的检测限)。

结论

发现用阿达帕林凝胶局部治疗痤疮安全有效,且有剂量相关反应。0.1%阿达帕林凝胶与0.025%维甲酸凝胶疗效无差异,但0.1%阿达帕林凝胶的皮肤耐受性更佳。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验